A carregar...
Feasibility of Aerosolized Alpha-1 Antitrypsin as a Therapeutic Option
Inhalation therapy is integral in the management of patients with chronic obstructive pulmonary disease (COPD). Specifically, intravenous augmentation therapy is available to patients with alpha-1 antitrypsin deficiency (AATD), although there is insufficient alpha-1 antitrypsin (AAT) delivery to the...
Na minha lista:
| Publicado no: | Chronic Obstr Pulm Dis |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
COPD Foundation Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857706/ https://ncbi.nlm.nih.gov/pubmed/32726075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.7.3.2019.0179 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|